Clinical trial
A Selective Androgen Receptor Modulator for Symptom Management in Prostate Cancer
NCT02499497
Study timeline
Study start (actual)2016-02-29Date precision: day
Registry last updated2021-09-28
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prostate Cancerunresolved
Interventions
Sponsors & collaborators
Dana-Farber Cancer Institutelead sponsor
National Institute of Nursing Research (NINR)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02499497 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.